Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...

The Aplastic Anemia market presents opportunities in novel therapies, with 5+ companies and 8+ drugs in various development stages. Key focus is on innovative treatment approaches, partnerships, and ...

Skin conditions, diet choices, and some chronic health conditions may make the bottom of your feet yellow. Treating the cause ...

Ayrmid Ltd. ("Ayrmid" or the "Company"), the parent company of Gamida Cell Inc., a cell therapy pioneer working to turn cells ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Researchers have developed a new iron supplement that pairs iron with prebiotics and probiotics to improve absorption and reduce side effects. Iron-deficiency anemia is a widespread condition that ...

Milk offers numerous health benefits, but it's not suitable for everyone. Individuals with lactose intolerance, milk protein ...

Indonesian nutritionist Mochammad Rizal has called for a thorough evaluation of the government’s Free Nutritional Meal ...

Manhattan Genomics is advancing next-generation medical technologies to correct harmful mutations at the embryonic stage. The company's singular mission is to prevent severe inherited conditions, such ...